Can philanthropic capital succeed where pharma failed in Gram-negative antibiotic discovery?
Will Gr-ADI fix the broken antibiotic pipeline? Explore how Gates, Novo, and Wellcome aim to reboot AMR innovation with $60M in global grants.
Pharma & Biotech